These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 32565725

  • 1. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
    Topkan E, Besen AA, Ozdemir Y, Kucuk A, Mertsoylu H, Pehlivan B, Selek U.
    Mediators Inflamm; 2020; 2020():4392189. PubMed ID: 32565725
    [Abstract] [Full Text] [Related]

  • 2. Systemic Inflammation Response Index Predicts Survival Outcomes in Glioblastoma Multiforme Patients Treated with Standard Stupp Protocol.
    Topkan E, Kucuk A, Ozdemir Y, Mertsoylu H, Besen AA, Sezen D, Bolukbasi Y, Pehlivan B, Selek U.
    J Immunol Res; 2020; 2020():8628540. PubMed ID: 33274245
    [Abstract] [Full Text] [Related]

  • 3. The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy.
    Brenner A, Friger M, Geffen DB, Kaisman-Elbaz T, Lavrenkov K.
    Oncology; 2019; 97(5):255-263. PubMed ID: 31288238
    [Abstract] [Full Text] [Related]

  • 4. Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide.
    Topkan E, Kucuk A, Selek U.
    J Immunol Res; 2022; 2022():1346094. PubMed ID: 36479136
    [Abstract] [Full Text] [Related]

  • 5. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
    Zhang Y, Chen Z, Jin F, Guo D, Chen Q, Liu Z, Ji S, Gao G.
    Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of the Glasgow Prognostic Score for glioblastoma multiforme patients treated with radiotherapy and temozolomide.
    Topkan E, Selek U, Ozdemir Y, Yildirim BA, Guler OC, Ciner F, Mertsoylu H, Tufan K.
    J Neurooncol; 2018 Sep; 139(2):411-419. PubMed ID: 29696530
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea.
    Kim BS, Seol HJ, Nam DH, Park CK, Kim IH, Kim TM, Kim JH, Cho YH, Yoon SM, Chang JH, Kang SG, Kim EH, Suh CO, Jung TY, Lee KH, Kim CY, Kim IA, Hong CK, Yoo H, Kim JH, Kang SH, Kang MK, Kim EY, Kim SH, Chung DS, Hwang SC, Song JH, Cho SJ, Lee SI, Lee YS, Ahn KJ, Kim SH, Lim DH, Gwak HS, Lee SH, Hong YK.
    Cancer Res Treat; 2017 Jan; 49(1):193-203. PubMed ID: 27384161
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic implications of the subcellular localization of survivin in glioblastomas treated with radiotherapy plus concomitant and adjuvant temozolomide.
    Saito T, Sugiyama K, Takeshima Y, Amatya VJ, Yamasaki F, Takayasu T, Nosaka R, Muragaki Y, Kawamata T, Kurisu K.
    J Neurosurg; 2018 Mar; 128(3):679-684. PubMed ID: 28430038
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical analysis of O6-methylguanine-DNA methyltransferase (MGMT) protein expression as prognostic marker in glioblastoma patients treated with radiation therapy with concomitant and adjuvant Temozolomide.
    Younis SG, Khedr RA, El-Shorbagy SH.
    J Egypt Natl Canc Inst; 2016 Mar; 28(1):23-30. PubMed ID: 26682634
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of preoperative neutrophil to lymphocyte ratio is superior to systemic immune inflammation index for survival in patients with Glioblastoma.
    Lv Y, Zhang S, Liu Z, Tian Y, Liang N, Zhang J.
    Clin Neurol Neurosurg; 2019 Jun; 181():24-27. PubMed ID: 30974296
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Huang T, Zhang H, Zhao Y, Li Y, Wang G, Zhang Y, Guo D, Ji S, Sun Z.
    Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
    [Abstract] [Full Text] [Related]

  • 16. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
    Wang Y, Lyu J, Jia H, Liang L, Xiao L, Liu Y, Liu X, Li K, Chen T, Zhang R, Zhang H, Tang C, Li T.
    Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
    [Abstract] [Full Text] [Related]

  • 17. A Cumulative Score Based on Preoperative Neutrophil-Lymphocyte Ratio and Fibrinogen in Predicting Overall Survival of Patients with Glioblastoma Multiforme.
    Hao Y, Li X, Chen H, Huo H, Liu Z, Tian F, Chai E.
    World Neurosurg; 2019 Aug; 128():e427-e433. PubMed ID: 31042598
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of preoperative hematological markers in patients with glioblastoma multiforme and construction of random survival forest model.
    Duan X, Yang B, Zhao C, Tie B, Cao L, Gao Y.
    BMC Cancer; 2023 May 12; 23(1):432. PubMed ID: 37173662
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
    Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim DH, Kim WS, Nam DH.
    Clin Neurol Neurosurg; 2009 Oct 12; 111(8):679-82. PubMed ID: 19640635
    [Abstract] [Full Text] [Related]

  • 20. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
    Shi X, Li H, Xu Y, Nyalali AMK, Li F.
    Neurol Sci; 2022 Sep 12; 43(9):5523-5531. PubMed ID: 35606674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.